Biologics for psoriasis in COVID-19 era: What do we know?
- PMID: 32338424
- PMCID: PMC7261982
- DOI: 10.1111/dth.13467
Biologics for psoriasis in COVID-19 era: What do we know?
Conflict of interest statement
The authors declare no potential conflict of interest.
Comment on
-
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22. Dermatol Ther. 2020. PMID: 32157783 Free PMC article. No abstract available.
References
-
- Ryzhakov G, Lai CC, Blazek K, To KW, Hussell T, Udalova I. IL‐17 boosts proinflammatory outcome of antiviral response in human cells. J Immunol. 2011;187(10):5357‐5362. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
